VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Consano Bio Launches Phase 1 Trial of C-1101, a First-in-Class Non-Opioid Biologic for Chronic Sciatica
Consano Bio Launches Phase 1 Trial of C-1101, a First-in-Class Non-Opioid Biologic for Chronic Sciatica
May 26, 2026 20:33 CST Updated 21:06
Share:
